HELIX-2, A Phase II Study of Samatasvir in Combination with Simeprevir, Low Dose Ritonavir-boosted TMC647055+Ribavirin in Treatment-naive or Interferon/ribavirin Treated, Relapsed Genotype 1 HCV-infected Subjects
HEPATOLOGY（2014）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined